AHA comments on ensuring legitimate access to controlled substances
The AHA today responded to a Department of Health and Human Services request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances, including opioids, while preventing diversion and abuse. The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 calls for HHS’ Office of the Assistant Secretary for Planning and Evaluation to submit a report to Congress on the issue. Among other actions, AHA recommends providing additional support for medical education, training and guidance for non-opioid pain management as well as for state drug courts, which offer justice-involved individuals with substance use disorders the opportunity to enter treatment programs.
Related News Articles
Perspective
This week, more than 1,000 hospital and health system leaders came to Washington, D.C., united by a shared responsibility: to ensure every community has access…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The Senate April 23 adopted a budget resolution by a 50-48 vote, paving the way for a narrow reconciliation bill focused on immigration enforcement funding.…
Perspective
Two days from now, the AHA will welcome more than 1,000 health care leaders to our 2026 Annual Membership Meeting in Washington, D.C.This yearly gathering…
Headline
Secretary of Health and Human Services Robert F. Kennedy Jr. April 16 testified during two House hearings on the HHS fiscal year 2027 budget proposal, which…
Perspective
Just 23 days from now, more than 1,000 hospital and health system leaders from across the country will arrive in Washington, D.C., for the 2026 AHA Annual…